carbocysteine has been researched along with Disease, Pulmonary in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nash, EF; Ratjen, F; Stephenson, A; Tam, J; Tullis, E | 1 |
| Ishibashi, Y; Kameda, T; Masuda, K; Matsuzawa, S; Nogawa, H; Ogawa, A; Tsubuki, T | 1 |
| Nash, EF; Ratjen, F; Stephenson, A; Tullis, E | 1 |
| Fossati, C | 1 |
3 review(s) available for carbocysteine and Disease, Pulmonary
| Article | Year |
|---|---|
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
Topics: Acetylcysteine; Administration, Inhalation; Administration, Oral; Ambroxol; Carbocysteine; Cystic Fibrosis; Expectorants; Glutathione; Humans; Lung Diseases; Mucociliary Clearance; Nebulizers and Vaporizers; Randomized Controlled Trials as Topic; Saline Solution, Hypertonic | 2013 |
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
Topics: Acetylcysteine; Administration, Inhalation; Administration, Oral; Ambroxol; Carbocysteine; Cystic Fibrosis; Expectorants; Humans; Lung Diseases; Mucociliary Clearance; Randomized Controlled Trials as Topic | 2009 |
[Treatment of serous and puruloid bronchial hypersecretions in acute and chronic bronchopneumopathies: our experience with a new mucolytic drug].
Topics: Acute Disease; Bronchial Diseases; Carbocysteine; Chronic Disease; Cysteine; Expectorants; Lung Diseases; Peptide Hydrolases | 1975 |
1 other study(ies) available for carbocysteine and Disease, Pulmonary
| Article | Year |
|---|---|
Carbocisteine can scavenge reactive oxygen species in vitro.
Topics: Animals; Bronchitis, Chronic; Carbocysteine; Cells, Cultured; Expectorants; Free Radical Scavengers; Humans; Lung Diseases; Oxidation-Reduction; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Rats; Rats, Wistar; Reactive Oxygen Species | 2009 |